Stockscreener 앱 받기
19.90
0.45%
-0.09
시간 외 거래:
19.95
0.05
+0.25%
전일 마감가:
$19.99
열려 있는:
$20
하루 거래량:
251.20K
Relative Volume:
1.28
시가총액:
$355.66M
수익:
$116.88M
순이익/손실:
$-25.09M
주가수익비율:
-142.14
EPS:
-0.14
순현금흐름:
$-20.74M
1주 성능:
-0.80%
1개월 성능:
+2.16%
6개월 성능:
-11.52%
1년 성능:
+87.56%
1일 변동 폭
$19.51
$20.22
1주일 범위
$19.51
$21.38
52주 변동 폭
$8.61
$29.82
Rigel Pharmaceuticals Stock (RIGL) Company Profile
명칭
Rigel Pharmaceuticals
전화
650-624-1100
주소
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
RIGL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RIGL
Rigel Pharmaceuticals
|
19.90 | 357.27M | 116.88M | -25.09M | -20.74M | -0.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.41 | 118.34B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.14 | 60.31B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.55 | 42.35B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.79 | 36.43B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
305.74 | 31.87B | 3.81B | -644.79M | -669.77M | -6.24 |
Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-04-03 | 재개 | Piper Sandler | Neutral |
| 2022-06-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-06-08 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-08 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-03-23 | 개시 | B. Riley Securities | Neutral |
| 2020-11-09 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-11-15 | 재개 | Cantor Fitzgerald | Overweight |
| 2019-09-26 | 재개 | JP Morgan | Overweight |
| 2019-03-01 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-08-27 | 개시 | Citigroup | Buy |
| 2018-05-02 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-12-21 | 재개 | Piper Jaffray | Overweight |
| 2017-12-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-11-06 | 재개 | H.C. Wainwright | Buy |
| 2017-03-09 | 재확인 | H.C. Wainwright | Buy |
| 2016-08-31 | 재확인 | H.C. Wainwright | Buy |
| 2016-08-30 | 재확인 | Piper Jaffray | Overweight |
| 2016-07-13 | 개시 | H.C. Wainwright | Buy |
| 2016-06-13 | 개시 | Piper Jaffray | Overweight |
| 2016-04-22 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2013-04-08 | 재확인 | Stifel | Buy |
| 2012-11-29 | 개시 | UBS | Neutral |
| 2012-11-06 | 재확인 | Oppenheimer | Outperform |
| 2012-03-26 | 개시 | Canaccord Genuity | Hold |
| 2010-12-10 | 다운그레이드 | MP Advisors | Outperform → Market Perform |
모두보기
Rigel Pharmaceuticals 주식(RIGL)의 최신 뉴스
Rigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and Business Update - Financial Times
How Resilient Is Rigel Pharmaceuticals Inc. Stock During Economic DownturnsCommunity Strategy With High Win Rate Backtested - metal.it
Will Rigel Pharmaceuticals Inc. Benefit From Broader Market BounceIntraday Trend Analysis for Fast Gains Released - metal.it
How does Rigel Pharmaceuticals Inc. generate profit in a changing economySuperior investment outcomes - jammulinksnews.com
What are the latest earnings results for Rigel Pharmaceuticals Inc.Invest smarter with expert stock recommendations - jammulinksnews.com
Should I hold or sell Rigel Pharmaceuticals Inc. stock in 2025Rapid growth trajectories - jammulinksnews.com
Is it the right time to buy Rigel Pharmaceuticals Inc. stockBuild a balanced portfolio for long-term success - jammulinksnews.com
What institutional investors are buying Rigel Pharmaceuticals Inc. stockSpectacular growth rates - jammulinksnews.com
How strong is Rigel Pharmaceuticals Inc. company’s balance sheetStay ahead with daily expert stock picks - jammulinksnews.com
Is Rigel Pharmaceuticals Inc. Stock a Smart Buy in 2025 Investment Analysis InsideBig Profit Small Risk Alerts - metal.it
Eli Lilly and Rigel Pharmaceuticals: Promising Advances in Rheumatoid Arthritis Treatment - TipRanks
Will Rigel Pharmaceuticals Inc. stock benefit from AI tech trendsHigh-impact stock picks - jammulinksnews.com
Is Rigel Pharmaceuticals Inc. a good long term investmentAccelerated wealth building - PrintWeekIndia
What institutions are buying Rigel Pharmaceuticals Inc. stock nowHigh-margin investment plays - jammulinksnews.com
What analysts say about Rigel Pharmaceuticals Inc. stockStrongest growth potential - PrintWeekIndia
What drives Rigel Pharmaceuticals Inc. stock priceHigh-margin investment plays - Autocar Professional
Institutional investors have a lot riding on Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) with 65% ownership - simplywall.st
Eli Lilly and Rigel Pharmaceuticals Advance Rheumatoid Arthritis Study with LY3871801 - TipRanks
Rigel Pharmaceuticals Inc. Stock Analysis and ForecastFastest-growing stock picks - jammulinksnews.com
(RIGL) Proactive Strategies - news.stocktradersdaily.com
What makes Rigel Pharmaceuticals Inc. stock price move sharplyHigh Potential Stock Ideas - newser.com
Why Rigel Pharmaceuticals Inc. stock attracts strong analyst attentionFree Top-Rated Stock Analysis - Newser
H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL) - Insider Monkey
(RIGL) Long Term Investment Analysis - news.stocktradersdaily.com
Rigel Pharmaceuticals (RIGL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
10.28%
2.59%
자본화:
|
볼륨(24시간):